EQH vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

EQH

31.9
AI Score
VS
IVZ Wins

IVZ

50.1
AI Score

Investment Advisor Scores

EQH

32score
Recommendation
SELL

IVZ

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EQH IVZ Winner
Revenue 3.57B 5.89B EQH
Net Income 558.00M 168.00M IVZ
Net Margin 15.6% 2.9% IVZ
ROE 4.5% -21.4% IVZ
ROA 2.0% 0.1% IVZ
Total Assets 27.47B 334.66B EQH
Cash 915.40M 17.18B EQH
Debt/Equity 0.13 -4.89 EQH

Relative Price Performance (Last 90 Days)

EQH 1M: +2.8% · 3M: +22.3% IVZ 1M: +2.3% · 3M: +14.1%

Current Technical Phase

EQH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 63

RSI (14): 63.0 · Price: $53.34

IVZ

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 53

RSI (14): 53.2 · Price: $32.28

Fundamentals Snapshot

Metric EQH IVZ
Market Cap
Forward P/E 5.9 9.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% 0.2%
Gross Margin 0.1% 0.3%
Operating Margin -0.3% 0.2%
EPS -3.32 -0.68
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.